Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

TXMD holding history

TherapeuticsMD, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXMD overviewAll 13F holders of TXMDFull Q2 2026 holdings

Shares (Q2 2026)
105,849
Value
$234.0K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TXMD by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026105,849$234.0K<0.1%−3,968−3.6%ReducedHolders
Q1 2026109,817$221.9K<0.1%+3,717+3.5%AddedHolders
Q4 2025106,100$173.0K<0.1%−2,983−2.7%ReducedHolders
Q3 2025109,083$115.7K<0.1%00.0%UnchangedHolders
Q2 2025109,083$126.6K<0.1%−2,425−2.2%ReducedHolders
Q1 2025111,508$103.2K<0.1%+3,175+2.9%AddedHolders
Q4 2024108,333$93.2K<0.1%00.0%UnchangedHolders
Q3 2024108,333$179.9K<0.1%+12,856+13.5%AddedHolders
Q2 202495,477$153.8K<0.1%+10,689+12.6%AddedHolders
Q1 202484,788$194.2K<0.1%00.0%UnchangedHolders
Q4 202384,788$190.8K<0.1%00.0%UnchangedHolders
Q3 202384,788$256.1K<0.1%+3,007+3.7%AddedHolders
Q2 202381,781$336.9K<0.1%00.0%UnchangedHolders
Q1 202381,781$306.7K<0.1%+14,835+22.2%AddedHolders
Q4 202266,946$374.0K<0.1%+66,946NewHolders
Q3 20220$00.0%−73,283−100.0%Sold outHolders
Q2 202273,283$729.0K<0.1%−59,278−44.7%ReducedConverted for a 1-for-50 splitHolders
Q1 20226,628,058$2.52M<0.1%+110,545+1.7%AddedHolders
Q4 20216,517,513$2.32M<0.1%−482,961−6.9%ReducedHolders
Q3 20217,000,474$5.19M<0.1%+820,453+13.3%AddedHolders
Q2 20216,180,021$7.35M<0.1%+623,917+11.2%AddedHolders
Q1 20215,556,104$7.45M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.